Biotech & Pharma

AstraZeneca recently received FDA approval to use Crestor, its blockbuster cholestrol drug, to treat children with extremely high levels of “bad” cholesterol. This is a rare condition, and is what could help the company extend patent protection on the drug. It’s also a group that could mean billons in dollars in sales. AstraZeneca wants to … Continue reading “AstraZeneca (AZN) Battles Crestor Competition”